REX FINANCIAL STATEMENTS

REX American Resources Corporation — balance sheet, income statement and cash flow trends

REXREX American Resources Corporation

🇺🇸 USA · NYSE · Basic Materials · Chemicals

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q2 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue656.2 M $+2.6%

Gross Profit108.4 M $+18.7%

Operating Income72 M $+11.9%

EBITDA118.7 M $+6.6%

Net Income92.7 M $+63.7%

Peer Comparison· Chemicals

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
REX	2.6%	16.5%	18.1%	14.1%
RDX	8.3%	21.5%	11.4%	6.3%
PETKM	2.4%	-2.1%	-7.1%	-7.5%
MX	-0.8%	15.2%	22.3%	-1.3%
BAS	-4.8%	24.3%	12.0%	2.9%
ACSEL	1.4%	9.5%	8.6%	-4.1%
Industry median	-2.4%	8.5%	6.1%	-3.8%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
REX	2.6%	16.5%	18.1%	14.1%
GPRE	-21.0%	5.8%	7.4%	-0.8%
HUN	-4.7%	12.9%	2.2%	-5.7%
TROX	-4.0%	6.4%	5.5%	-15.8%
OLN	2.6%	6.4%	7.4%	-1.9%
LXU	21.5%	19.6%	25.6%	7.2%
Industry median	-2.4%	8.5%	6.1%	-3.8%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q2 2026

Equity629.2 M $88%
Current Liabilities65.3 M $9%
Long-term Liabilities18.6 M $3%

Key Figures

YoY change

Total Assets807.7 M $+16.4%

Total Liabilities83.9 M $+13.1%

Total Equity629.2 M $+17.3%

Cash & ST Investments364.3 M $+15.3%

Total Debt19.5 M $-25.4%

Net Debt-98.1 M $—

Peer Comparison· Chemicals

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
REX	6.76	3.1%	-2.90	77.9%
RDX	3.99	12.6%	-0.52	74.1%
PETKM	0.56	76.7%	-6.76	41.2%
MX	1.96	143.4%	3.76	33.4%
BAS	1.91	69.0%	2.84	41.9%
ACSEL	1.17	25.5%	2.14	63.4%
Industry median	1.88	73.9%	3.30	41.6%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
REX	6.76	3.1%	-2.90	77.9%
GPRE	1.71	71.2%	2.62	49.5%
HUN	1.18	92.8%	17.08	37.6%
TROX	2.42	268.7%	20.77	21.3%
OLN	1.36	190.9%	6.30	23.6%
LXU	3.07	90.6%	1.89	45.6%
Industry median	1.88	73.9%	3.30	41.6%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q2 2026 · TTM

Key Figures

YoY change

Operating Cash Flow119.2 M $+89.3%

Capital Expenditures73.2 M $+37.1%

Free Cash Flow46 M $+379.9%

Dividends Paid——

Peer Comparison· Chemicals

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
REX	18.2%	7.0%	11.2%	128.6%
RDX	7.6%	7.2%	0.4%	121.6%
PETKM	3.3%	6.3%	4.7%	-43.8%
MX	18.2%	16.2%	2.0%	-1,449.4%
BAS	9.6%	2.9%	6.7%	333.4%
ACSEL	13.8%	15.1%	1.3%	-339.7%
Industry median	6.7%	3.7%	4.0%	-24.4%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
REX	18.2%	7.0%	11.2%	128.6%
GPRE	6.0%	4.6%	1.4%	-759.3%
HUN	5.4%	2.4%	3.1%	-95.7%
TROX	0.8%	-9.4%	10.2%	-5.0%
OLN	7.6%	4.5%	3.1%	-402.8%
LXU	21.9%	22.5%	17.0%	305.8%
Industry median	6.7%	3.7%	4.0%	-24.4%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on REX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.